Informed Consent Process

Informed Consent Process - Axcellant

Informed Consent Process

  1. lut 28, 2025

What Does the 'Informed Consent Process’ Mean?

The informed consent process is a crucial ethical and legal procedure in clinical research. It involves providing potential study participants with comprehensive information about a clinical trial, including its purpose, procedures, risks, benefits, and alternatives, to enable them to make an informed decision about participation.

This process encompasses more than just signing a document; it involves ongoing communication between researchers and participants. The informed consent process ensures that participants understand their rights, responsibilities, and the voluntary nature of their involvement, and it continues throughout the duration of the study.

Why Is the 'Informed Consent Process’ Important in Clinical Research?

The informed consent process is fundamental to ethical clinical research as it safeguards participants’ autonomy and wellbeing. It ensures that individuals are fully aware of what their participation entails, allowing them to make voluntary decisions based on accurate information about potential risks and benefits.

This process is also crucial for maintaining the integrity and credibility of clinical studies. By promoting transparency and trust between researchers and participants, it helps to protect the rights of study subjects and supports the collection of valid, reliable data for advancing medical knowledge and treatments.

Good Practices and Procedures

  1. Utilize multimedia tools such as videos or interactive presentations to enhance comprehension of complex study information
  2. Implement a „teach-back” method where participants explain key study aspects in their own words to confirm understanding
  3. Conduct periodic re-consent processes for long-term studies to address any protocol changes or new findings
  4. Offer multiple opportunities for participants to ask questions, including follow-up contacts after initial consent
  5. Employ culturally sensitive approaches, including providing translated materials and interpreters when necessary

Related Terms

Read more

How clinical trials can become a strategic asset for biotech startups

Clinical trials are often seen as a regulatory necessity, but for biotech and medtech startups, they can be much more.…

Advancing PET Innovation at SNMMI 2025

Axcellant participated in SNMMI’s 2025 Annual Meeting in New Orleans, where nearly 8,000 professionals in nuclear medicine and molecular imaging gathered…

Insights from Turku PET Symposium 2025

Axcellant participated in the PET Symposium 2025, held in Turku, marking 50 years of PET radiochemistry at the Turku PET…